3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Thyroid Cancer, Papillary
2
Thyroid Diseases
1
Hypothyroidism
1
Interventions
Sorafenib
3
cabozantinib
2
Sodium
2
Radiofrequency Ablation
2
Metformin
2
Data Collection
2
vandetanib
1
temsirolimus
1
selpercatinib
1
pembrolizumab
1
lenvatinib
1
apatinib
1
acetaminophen, codeine drug combination
1
Watchful Waiting
1
Tramadol
1
Thyroxine
1
Thyroidectomy
1
Thyroid (USP)
1
Technetium Tc 99m Sestamibi
1
Panobinostat
1
Observation
1
Negative-Pressure Wound Therapy
1
NAc-Sar-Gly-Val-(d-allo-Ile)-Thr-Nva-Ile-Arg-ProNEt
1
Lysine Acetyltransferase 5
1
Iodine-131
1
Interviews as Topic
1
Indocyanine Green
1
Hyperspectral Imaging
1
Focus Groups
1
Fluorescein
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Thyroid Diseases
×
Thyroid (USP)
×
Clear all
NCT07239674
2025-11-20
DELTA
West China Hospital
Phase 3
Not yet recruiting
646 enrolled